The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Nivolumab Boosted Survival in Relapsed Mesothelioma

KEYNOTE-598: Dual PD-1 and CTLA-4 Checkpoint Blockade Confers No Therapeutic Benefit Beyond PD-1 Blockade Alone in PD-L1–Positive NSCLC

LCMC3 Findings Indicate Neoadjuvant Atezolizumab Safe, Efficacious in Resectable Stage IB-IIIB NSCLC

Genetically Tailored Treatment Approach Did Not Improve Survival in Stage II-III NSCLC

The Evolution of Palliative Care for Metastatic Lung Cancer

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

Veterans Health Administration’s Lung Precision Oncology Program Helps Individualize Treatment

Management of Breathlessness in Lung Cancer Post-Surgery: An Interview With U.S. and U.K. Nurses

Mitigating Pain in Thoracic Surgery

Multidisciplinary Teams at AUSL Romagna